派林生物：上半年净利润2.36亿元 同比降27.89%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first half of 2025 was 986 million yuan, a year-on-year decrease of 13.18% [1] - The net profit for the same period was 236 million yuan, reflecting a year-on-year decline of 27.89% [1] Dividend Policy - The company announced that it will not distribute cash dividends, issue bonus shares, or increase share capital from reserves [1]